SCHEMBL2117131

SCHEMBL2117131

Nc1nc(C2OC[C@@H](O)[C@H]2O)nc2nc[nH]c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.45
GDA Q9Y2T3 1/20 0.45
PI4KA P42356 2/20 0.36
PI4K2B Q8TCG2 2/20 0.36
PI4K2A Q9BTU6 2/20 0.36
PI4KB Q9UBF8 2/20 0.36
LMNA P02545 1/20 0.36
DRD3 P35462 1/20 0.36
XDH P47989 1/20 0.36
LRRK2 Q5S007 1/20 0.36
KDR P35968 1/20 0.36
AURKB Q96GD4 1/20 0.36
CDK2 P24941 3/20 0.34
DPP4 P27487 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
POLA1 P09884 1/20 0.33
PNP P00491 1/20 0.33
ADK P55263 1/20 0.32
CDK1 P06493 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2983115 0.97 PDPK1 (0.45) PDPK1GDAPI4KAPI4K2BPI4K2A
Water SCHEMBL27761338 0.96 PDPK1 (0.44) PDPK1GDAPI4KAPI4K2BPI4K2A
SCHEMBL7638547 0.85 PDPK1 (0.41) PDPK1GDAPI4KAPI4K2BPI4K2A
SCHEMBL2117124 0.79 ADORA2A (0.34) ADORA2AADORA1ADK
SCHEMBL29383125 0.79 ADORA2A (0.34) ADORA2AADORA1ADK
SCHEMBL27595472 0.77 PDPK1 (0.40) PDPK1GDAPI4KAPI4K2BPI4K2A
SCHEMBL2983106 0.76 ADORA2A (0.34) ADORA2AADORA1PNPADK
SCHEMBL28530829 0.75 PDPK1 (0.41) PDPK1GDAPI4KAPI4K2BPI4K2A
2,6-Diaminopurine SCHEMBL443468 0.75 PDPK1 (0.55) PDPK1GDACDK2DPP4ADORA2A
SCHEMBL2010793 0.74 PDPK1 (0.43) PDPK1GDALMNAKDRAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130030007-A1 Obesity Small Molecules AKRON MOLECULES GMBH (AT) 2013-01-31 US disclosed
EP-2521594-A2 OBESITY SMALL MOLECULES Akron Molecules GmbH (AT) 2012-11-14 EP disclosed
US-20120094947-A1 METHOD FOR THE SELECTIVE THERAPY OF DISEASE LUBIN ADAM (US) 2012-04-19 US disclosed
WO-2011083150-A2 OBESITY SMALL MOLECULES AKRON MOLECULES GMBH (AT) 2011-07-14 WO disclosed
EP-2192905-A2 METHOD FOR THE SELECTIVE THERAPY OF DISEASE Lubin, Adam (US) 2010-06-09 EP disclosed
WO-2009032057-A2 METHOD FOR THE SELECTIVE THERAPY OF DISEASE LUBIN ADAM (US) 2009-03-12 WO disclosed